{
    "clinical_study": {
        "@rank": "127767", 
        "arm_group": [
            {
                "arm_group_label": "NPPV+IMT", 
                "arm_group_type": "Experimental", 
                "description": "noninvasive positive pressure ventilation and inspiratory muscle training"
            }, 
            {
                "arm_group_label": "NPPV", 
                "arm_group_type": "Active Comparator", 
                "description": "noninvasive positive pressure ventilation"
            }, 
            {
                "arm_group_label": "IMT", 
                "arm_group_type": "Active Comparator", 
                "description": "inspiratory muscle training"
            }, 
            {
                "arm_group_label": "LTOT", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Long time oxygen therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to determine whether noninvasive positive pressure ventilation with\n      inspiratory muscle training can improve quality of life and respiratory muscle strength than\n      noninvasive positive pressure ventilation or inspiratory muscle training alone."
        }, 
        "brief_title": "NPPV Added Inspiratory Muscle Training in Severe COPD", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Obstructive Pulmonary Disease", 
            "Hypercapnic Respiratory Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Hypercapnia", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Hypoventilation", 
                "Respiratory Insufficiency", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Aged 40-75 years, male or female.\n\n          2. Have spirometric evidence of COPD with an FEV1 of < 50% predicted and FEV1/FVC <\n             0.70, measured within the last 6 months (GOLD stage III and IV). Stable disease since\n             4 weeks or more prior to randomisation.\n\n          3. PCO2 of 7 kPa, combined with a pH of 7.35 or above. These gases must be measured\n             after 30 minutes breathing room air in sitting position\n\n          4. No treatment with NPPV and respiratory muscle training in the last 8 weeks\n\n        Exclusion Criteria:\n\n          1. Smokers can be excluded;\n\n          2. Diseases of the lung or thorax besides COPD: OSA Advanced pulmonary fibrosis,\n             advanced bronchiectases, active tuberculosis, post tuberculosis syndrome, pneumonia,\n             severe kyphoscoliosis, tracheostoma, neuromuscular diseases, or any other disorder,\n             which might result in elevated PCO2\n\n          3. Body mass index of 35 kg/m\u00b2 or above. Severe cardiac disease, NYHA IV, instable\n             angina, severe cardiac arrhythmia, especially of ventricular origin (atrial\n             fibrillation is not an exclusion criterion).\n\n          4. Local derangement of the face, skin, tongue, upper airways, larynx and upper\n             oesophagus.\n\n          5. Severe chronic diseases except COPD, hindering the patient to follow the schedule of\n             this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926275", 
            "org_study_id": "GZIRD-201308"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "NPPV", 
                    "IMT", 
                    "LTOT"
                ], 
                "description": "noninvasive positive pressure ventilation and inspiratory muscle training", 
                "intervention_name": "NPPV+IMT", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "NPPV+IMT", 
                    "IMT", 
                    "LTOT"
                ], 
                "description": "noninvasive positive pressure ventilation", 
                "intervention_name": "NPPV", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "NPPV+IMT", 
                    "NPPV", 
                    "LTOT"
                ], 
                "description": "inspiratory muscle training", 
                "intervention_name": "IMT", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "Noninvasive Positive Pressure Ventilation", 
            "Respiratory Muscle Training"
        ], 
        "lastchanged_date": "August 18, 2013", 
        "location": {
            "contact": {
                "email": "zhlx09@163.com", 
                "last_name": "LuQian Zhou, Doctor", 
                "phone": "+86-15622236759"
            }, 
            "facility": {
                "address": {
                    "city": "Canton", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510120"
                }, 
                "name": "Guangzhou Institute of Respiratory Disease"
            }, 
            "investigator": {
                "last_name": "LuQian Zhou, Doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Noninvasive Positive Pressure Ventilation Added Inspiratory Muscle Training in Severe Chronic Obstructive Pulmonary Disease", 
        "overall_contact": {
            "email": "zhlx09@163.com", 
            "last_name": "LuQian Zhou, Doctor", 
            "phone": "+86-15622236759"
        }, 
        "overall_official": {
            "affiliation": "Guangzhou Institute of Respiratory Disease", 
            "last_name": "LuQian Zhou, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Severe Respiratory Insufficiency (SRI) Questionnaire and chronic obstructive pulmonary disease assessment test(CAT)", 
            "measure": "Quality of life", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in  quality of life at 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926275"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Guangzhou Institute of Respiratory Disease", 
            "investigator_full_name": "LuQian Zhou", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "respiratory muscle strength", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in respiratory muscle strength at 8 weeks"
            }, 
            {
                "description": "baseline dyspnea index (BDI)and transition dyspnea index(TDI)", 
                "measure": "Dyspnea", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in  dyspnea at 8 weeks"
            }, 
            {
                "description": "Change from baseline in distance walked test 6-minute walk test at 8 week", 
                "measure": "Walked distance in 6MWT", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in walked distance at 8 weeks"
            }, 
            {
                "measure": "Frequency of acute exacerbations of COPD", 
                "safety_issue": "No", 
                "time_frame": "8 week"
            }, 
            {
                "measure": "Pulmonary function tests", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in pulmonary function tests at 8 weeks"
            }, 
            {
                "measure": "Blood gases levels", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in  blood gases levelsat 8 weeks"
            }, 
            {
                "description": "Epworth\u00b4s Sleepiness Scale", 
                "measure": "Sleep quality", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in  sleep qualityat 8 weeks"
            }, 
            {
                "measure": "Length of hospital admission", 
                "safety_issue": "No", 
                "time_frame": "8 week"
            }, 
            {
                "measure": "frequency of  of hospital admission", 
                "safety_issue": "No", 
                "time_frame": "8 week"
            }
        ], 
        "source": "Guangzhou Institute of Respiratory Disease", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Guangzhou Institute of Respiratory Disease", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}